232 related articles for article (PubMed ID: 7779872)
1. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method].
Quindós G; San Millán R; Burgos A; Lipperheide V; Tellaetxe M; Alonso R; Barturen B; Pontón J
Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
Balaban N; Karahan ZC; Mumcuoğlu I; Cayirli A; Kuştimur S
Mikrobiyol Bul; 2007 Apr; 41(2):245-51. PubMed ID: 17682711
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of a new automated system for the determination of antifungal sensitivity].
Lozano MC; Parras P; Martín E
Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):135-8. PubMed ID: 8499512
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
de Montclos M; de Montclos H; Flandrois JP
Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
[TBL] [Abstract][Full Text] [Related]
7. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients].
Dieng Y; Faye-Niang MA; Ndour-Diop A; Sow PS; Dieng T; Soumare M; Bah IB; Faye O; Diop BM; Gaye O; Ndir O; Diallo S
Dakar Med; 2001; 46(1):4-7. PubMed ID: 15773146
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Candida species strains to five antifungal agents: comparison between agar dilution and disk diffusion tests.
Trancassini M; Ghezzi MC; Cipriani P; Mancini C; Brenciaglia MI
Chemioterapia; 1986 Feb; 5(1):14-7. PubMed ID: 3955776
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
Liu XP; Fan SR; Bai FY; Li J; Liao QP
Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
[TBL] [Abstract][Full Text] [Related]
14. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
15. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
16. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
[TBL] [Abstract][Full Text] [Related]
17. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
[TBL] [Abstract][Full Text] [Related]
18. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens.
Ellabib MS; ElJariny IA
Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942
[TBL] [Abstract][Full Text] [Related]
20. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Guinet R
Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
